Cargando…

The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer

SIMPLE SUMMARY: Bladder cancer is one of the most common urological malignancies. Despite the continuous improvement of diagnosis and treatment in recent years, the high recurrence rate and poor prognosis of bladder cancer often led to poor quality of life. In the past few years, emerging evidence h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Feng, Yanfei, Zheng, Xiangyi, Xu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954389/
https://www.ncbi.nlm.nih.gov/pubmed/36831352
http://dx.doi.org/10.3390/cancers15041007
_version_ 1784894105904480256
author Wang, Hao
Feng, Yanfei
Zheng, Xiangyi
Xu, Xin
author_facet Wang, Hao
Feng, Yanfei
Zheng, Xiangyi
Xu, Xin
author_sort Wang, Hao
collection PubMed
description SIMPLE SUMMARY: Bladder cancer is one of the most common urological malignancies. Despite the continuous improvement of diagnosis and treatment in recent years, the high recurrence rate and poor prognosis of bladder cancer often led to poor quality of life. In the past few years, emerging evidence has demonstrated that long noncoding RNAs play a crucial role in the carcinogenesis and progression of bladder cancer. Small nucleolar RNAs (snoRNAs) and long intergenic noncoding RNAs (lincRNAs) are both subclasses of lncRNAs, and their dysregulation has been proven to be closely related to tumour growth and metastasis. In this review, we focus on the recently published literature on snoRNAs and lincRNAs in bladder cancer and summarize the important role of snoRNA and lincRNA in the carcinogenesis and development of bladder cancer. Our work contributes to a better understanding of the specific mechanism of the role of snoRNA and lincRNA in bladder cancer and reveals their potential as diagnostic biomarkers and therapeutic targets. ABSTRACT: Bladder cancer is one of the most common malignancies of the urinary tract and can be divided into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Although the means of diagnosis and treatment have continually improved in recent years, the recurrence rate of bladder cancer remains high, and patients with MIBC typically have an unfavourable prognosis and a low quality of life. Emerging evidence demonstrates that long noncoding RNAs play a crucial role in the carcinogenesis and progression of bladder cancer. Long intergenic noncoding RNAs (lincRNAs) are a subgroup of long noncoding RNAs (lncRNAs) that do not overlap protein-coding genes. The potential role of lincRNAs in the regulation of gene expression has been explored in depth in recent years. Small nucleolar RNAs (snoRNAs) are a class of noncoding RNAs (ncRNAs) that mainly exist in the nucleolus, are approximately 60–300 nucleotides in length, and are hosted inside the introns of genes. Small nucleolar RNA host genes (SNHGs) have been associated with the origin and development of bladder cancer. In this review, we aim to comprehensively summarize the biological functions of these molecules in bladder cancer.
format Online
Article
Text
id pubmed-9954389
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99543892023-02-25 The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer Wang, Hao Feng, Yanfei Zheng, Xiangyi Xu, Xin Cancers (Basel) Review SIMPLE SUMMARY: Bladder cancer is one of the most common urological malignancies. Despite the continuous improvement of diagnosis and treatment in recent years, the high recurrence rate and poor prognosis of bladder cancer often led to poor quality of life. In the past few years, emerging evidence has demonstrated that long noncoding RNAs play a crucial role in the carcinogenesis and progression of bladder cancer. Small nucleolar RNAs (snoRNAs) and long intergenic noncoding RNAs (lincRNAs) are both subclasses of lncRNAs, and their dysregulation has been proven to be closely related to tumour growth and metastasis. In this review, we focus on the recently published literature on snoRNAs and lincRNAs in bladder cancer and summarize the important role of snoRNA and lincRNA in the carcinogenesis and development of bladder cancer. Our work contributes to a better understanding of the specific mechanism of the role of snoRNA and lincRNA in bladder cancer and reveals their potential as diagnostic biomarkers and therapeutic targets. ABSTRACT: Bladder cancer is one of the most common malignancies of the urinary tract and can be divided into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Although the means of diagnosis and treatment have continually improved in recent years, the recurrence rate of bladder cancer remains high, and patients with MIBC typically have an unfavourable prognosis and a low quality of life. Emerging evidence demonstrates that long noncoding RNAs play a crucial role in the carcinogenesis and progression of bladder cancer. Long intergenic noncoding RNAs (lincRNAs) are a subgroup of long noncoding RNAs (lncRNAs) that do not overlap protein-coding genes. The potential role of lincRNAs in the regulation of gene expression has been explored in depth in recent years. Small nucleolar RNAs (snoRNAs) are a class of noncoding RNAs (ncRNAs) that mainly exist in the nucleolus, are approximately 60–300 nucleotides in length, and are hosted inside the introns of genes. Small nucleolar RNA host genes (SNHGs) have been associated with the origin and development of bladder cancer. In this review, we aim to comprehensively summarize the biological functions of these molecules in bladder cancer. MDPI 2023-02-04 /pmc/articles/PMC9954389/ /pubmed/36831352 http://dx.doi.org/10.3390/cancers15041007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wang, Hao
Feng, Yanfei
Zheng, Xiangyi
Xu, Xin
The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title_full The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title_fullStr The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title_full_unstemmed The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title_short The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer
title_sort diagnostic and therapeutic role of snorna and lincrna in bladder cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954389/
https://www.ncbi.nlm.nih.gov/pubmed/36831352
http://dx.doi.org/10.3390/cancers15041007
work_keys_str_mv AT wanghao thediagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT fengyanfei thediagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT zhengxiangyi thediagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT xuxin thediagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT wanghao diagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT fengyanfei diagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT zhengxiangyi diagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer
AT xuxin diagnosticandtherapeuticroleofsnornaandlincrnainbladdercancer